These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34171762)

  • 21. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study.
    McCabe SE; West BT
    J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Smit F; Vollebergh WA; Spijker J
    Am J Psychiatry; 2002 Apr; 159(4):620-9. PubMed ID: 11925301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders? An analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Hoertel N; Falissard B; Humphreys K; Gorwood P; Seigneurie AS; Limosin F
    J Clin Psychiatry; 2014 Mar; 75(3):231-7. PubMed ID: 24569017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
    J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.
    Wu LT; Ghitza UE; Batch BC; Pencina MJ; Rojas LF; Goldstein BA; Schibler T; Dunham AA; Rusincovitch S; Brady KT
    Drug Alcohol Depend; 2015 Nov; 156():162-169. PubMed ID: 26392231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probability and predictors of first treatment contact for anxiety disorders in the United States: analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Iza M; Olfson M; Vermes D; Hoffer M; Wang S; Blanco C
    J Clin Psychiatry; 2013 Nov; 74(11):1093-100. PubMed ID: 24330896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey.
    Kessler RC; Davis CG; Kendler KS
    Psychol Med; 1997 Sep; 27(5):1101-19. PubMed ID: 9300515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for secondary substance use disorders in people with childhood and adolescent-onset bipolar disorder: opportunities for prevention.
    Kenneson A; Funderburk JS; Maisto SA
    Compr Psychiatry; 2013 Jul; 54(5):439-46. PubMed ID: 23332720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considering comorbidity in social phobia.
    Chartier MJ; Walker JR; Stein MB
    Soc Psychiatry Psychiatr Epidemiol; 2003 Dec; 38(12):728-34. PubMed ID: 14689178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unintentional alcohol and drug poisoning in association with substance use disorders and mood and anxiety disorders: results from the 2010 Nationwide Inpatient Sample.
    Yoon YH; Chen CM; Yi HY
    Inj Prev; 2014 Feb; 20(1):21-8. PubMed ID: 23710064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III.
    Goldstein RB; Smith SM; Chou SP; Saha TD; Jung J; Zhang H; Pickering RP; Ruan WJ; Huang B; Grant BF
    Soc Psychiatry Psychiatr Epidemiol; 2016 Aug; 51(8):1137-48. PubMed ID: 27106853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spectrum of substance use in mood and anxiety disorders.
    Sbrana A; Bizzarri JV; Rucci P; Gonnelli C; Doria MR; Spagnolli S; Ravani L; Raimondi F; Dell'Osso L; Cassano GB
    Compr Psychiatry; 2005; 46(1):6-13. PubMed ID: 15714188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking.
    Moss HB; Chen CM; Yi HY
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1073-83. PubMed ID: 20374206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders.
    Regier DA; Rae DS; Narrow WE; Kaelber CT; Schatzberg AF
    Br J Psychiatry Suppl; 1998; (34):24-8. PubMed ID: 9829013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age at immigration to Canada and the occurrence of mood, anxiety, and substance use disorders.
    Patterson B; Kyu HH; Georgiades K
    Can J Psychiatry; 2013 Apr; 58(4):210-7. PubMed ID: 23547644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.